MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy
Conditions: Cervical Cancer; Radiotherapy; Prognostic Model; MRI Interventions: Radiation: Treatment mainly composed of external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT) . Sponsors: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
Conditions: Brachytherapy; Desmoid Tumor; Radioactive Iodine-125 Seed Implantation Interventions: Radiation: CT-guided radioactive iodine-125 seed implantation Sponsors: Peking University Third Hospital; First Affiliated Hospital of the Army Medical University; Shengli Oilfield Central Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Conditions: Breast Cancer Interventions: Radiation: Accelerated partial breast irradiation Sponsors: Virginia Commonwealth University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Induction of double-strand breaks with the non-steroidal androgen receptor ligand flutamide in patients on androgen suppression: a study protocol for a randomized, double-blind prospective trial
This study will confirm in humans the pharmacodynamic effect of AR ligands to induce transient double-strand breaks when administered in the context of androgen deprivation as a novel therapy for prostate cancer. The findings of this study will permit the development of a larger trial evaluating flutamide pulsed-dose sequencing in association with fractionated external beam RT (+/ − brachytherapy). The study is ongoing, and preliminary data collection and recruitment are underway; analysis has yet to be performed.Trial registrationClinicalTrials.gov NCT03507608. Prospectively registered on 25 April 2018. (Source: Trials)
Source: Trials - December 16, 2023 Category: Research Source Type: clinical trials
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
Conditions: Stage IIC Prostate Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8 Interventions: Procedure: Biospecimen Collection; Procedure: Bone Scan; Radiation: Brachytherapy; Procedure: Computed Tomography; Procedure: Dual X-ray Absorptiometry; Radiation: External Beam Radiation Therapy; Procedure: Magnetic Resonance Imaging; Procedure: PSMA PET Scan; Other: Questionnaire Administration; Drug: Relugolix Sponsors: University of Kansas Medical Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
Conditions: Cervical Cancer; Radiotherapy; Distant Metastasis; Prognostic Model; Risk Factor Interventions: Radiation: external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT) Sponsors: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Feasibility of the Maastro Applicator in Rectal Cancer
Conditions: Rectal Cancer; Feasibility; Toxicity; Quality of Life; Radiation Toxicity; Radiation Proctitis; Brachytherapy; Complete Response Interventions: Device: Maastro applicator Sponsors: Maastricht Radiation Oncology; Varian Medical Systems Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source
Conditions: Prostate Cancer Interventions: Radiation: Focal Brachytherapy Sponsors: Herlev Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer
Conditions: Cervical Cancer Interventions: Radiation: Iodine-125 particle brachytherapy; Drug: AK104 Sponsors: Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
Hand Massage on Fatigue With Cancer Receiving Brachytherapy
Condition: Hand Massage Intervention: Behavioral: Hand Massage Sponsor: TC Erciyes University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Hand Massage on Fatigue With Cancer Receiving Brachytherapy
Conditions: Hand Massage Interventions: Behavioral: Hand Massage Sponsors: TC Erciyes University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.
Condition: Prostate Cancer Interventions: Radiation: Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant; Radiation: Stereotactic Body Radiation Therapy to the prostate Sponsor: CHU de Quebec-Universite Laval Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
